Bile Duct Injury Settlement Amounts by Strasberg Class

Before any number belongs on a page like this, the source of the number has to be disclosed. That is the honest starting point, and it matters — particularly because settlement content is regulated and readers tend to remember the high end of a range long after they have forgotten the qualifiers attached to it.

The ranges below are built from three converging sources. First, published verdict and settlement databases — Jury Verdict Research, VerdictSearch, and the reported jury-verdict reporters in states with robust publication practice (Illinois, New York, Florida, California, Pennsylvania). Second, the peer-reviewed surgical literature — the outcome series published in Annals of Surgery, the Journal of the American College of Surgeons, and HPB, which report long-term morbidity after bile duct reconstruction and the life-care implications that drive damages. Third, the working knowledge of national medical-malpractice practice — the settlement figures that do not appear in any public database because they were resolved under confidentiality agreements.

What none of these sources do, individually or collectively, is tell you what your case is worth. Published ranges are aggregates. Your case is specific. That distinction is not a hedge. It is the entire point. A 34-year-old surgeon with a Type E2 injury and a successful reconstruction resolves differently from a 72-year-old retiree with the same injury. A case filed in Florida after the Kalitan decision (2017) resolves differently from the same facts in Texas under the § 74.301 non-economic cap. Aggregates tell you what patterns exist. They do not tell you where your case sits inside those patterns.

The Model Rules of Professional Conduct speak to this directly. Rule 1.5 governs contingency fees, and Rule 7.1 prohibits misleading communications about legal services — including communications that imply guaranteed results. Every figure below is published with that rule in front of it.

Type A injuries in the Strasberg classification are bile leaks from the cystic-duct stump or peripheral minor ducts — the most common injury pattern, typically manageable with endoscopic retrograde cholangiopancreatography (ERCP) and temporary stent placement without open reconstruction. Recovery is measured in weeks rather than decades, and the long-term functional picture is usually good.

Case-value patterns at the low end: when the leak is recognized promptly (within 48 to 72 hours of cholecystectomy), managed with one ERCP and a biliary stent, and the patient has a three- to six-week course with no sequelae, published verdict and settlement data shows a general range in the low six figures — roughly $100,000 to $400,000. These are patterns observed in comparable cases. No attorney can promise any specific number.

Case-value patterns at the high end of Type A: when the leak is missed for a clinically meaningful period, the patient develops biliary peritonitis, requires ICU admission for sepsis, and carries residual functional limitation, the damages model changes meaningfully. The same Type A injury with a two-week diagnostic delay and subsequent sepsis can settle in the mid six figures — sometimes approaching seven figures in jurisdictions with no non-economic caps and when the delay itself is the core negligence theory.

The takeaway is that injury class alone does not determine case value. Time-to-diagnosis, complication burden, and jurisdiction reshape the range meaningfully. A firm that quotes you a Type A number without pulling the records first is not doing the work.

Types B and C describe injuries to an aberrant (or accessory) right hepatic duct — B is occlusion, C is transection of the aberrant duct. These are less common than Type A but clinically significant because they can produce segmental liver atrophy, chronic cholangitis, or late stricture of the affected liver segment, and the management pathway is not always straightforward.

Published patterns for Type B injuries — where an accessory duct is clipped and the segment it drains atrophies silently — often resolve in the mid six figures, in the general range of $350,000 to $800,000, when the atrophy is partial and asymptomatic. When the clipped duct produces symptomatic cholangitis requiring intervention, the range moves upward.

Type C injuries — transection of an aberrant right hepatic duct — present a more complex reconstruction decision. Segmental resection, hepaticojejunostomy to the aberrant duct, and observation each have published support depending on the anatomy, and the long-term outcome varies. Case-value patterns typically cluster in the mid to high six figures when reconstruction is successful and functional impairment is limited, trending into seven figures when complications recur over time.

These ranges are general patterns observed in the published verdict literature and reported case series. They are not guarantees and they are not predictions of what any individual case will resolve for. The reconstruction quality, the long-term imaging, the frequency of cholangitis episodes, and the jurisdiction together shape the specific outcome.

Type D injuries are partial injuries to a major bile duct — the common hepatic duct, the common bile duct, or the right or left hepatic duct — without complete transection. Management can range from T-tube placement and primary repair to eventual hepaticojejunostomy if the injury progresses to stricture, which it frequently does. The natural history of a Type D injury is often not apparent in the first six months; late stricture is the characteristic long-term complication.

Published settlement and verdict patterns for Type D cases show a general range of mid six to low seven figures — roughly $500,000 to $1.5 million in cases that have a clear liability story and moderate long-term impact. When the injury progresses to stricture requiring one or more ERCP dilations or eventual surgical revision, the life-care plan grows and the total damages model scales upward.

Type D injuries are the injuries most affected by time-to-diagnosis and intraoperative recognition. A Type D injury recognized during the index cholecystectomy and repaired by a hepatobiliary surgeon on the same admission has a measurably different long-term outcome — and therefore a measurably different damages profile — than the same injury missed and diagnosed six weeks later when the patient presents with jaundice or cholangitis. Intraoperative recognition is published in the surgical literature as one of the most powerful predictors of long-term outcome, and it sits squarely inside the negligence analysis.

None of these numbers are case-specific. They are patterns observed in comparable cases, published in verdict databases and reflected in the outcome series from academic hepatobiliary centers. Your case is evaluated on its records and its jurisdiction, not on any range.

Types E1 and E2 are complete transections of the common hepatic duct — E1 with more than 2 cm of healthy duct remaining proximal to the injury, E2 with less than 2 cm. Both require Roux-en-Y hepaticojejunostomy reconstruction, both carry a long-term stricture risk in the 10% to 30% range depending on surgical expertise and timing, and both generate significant life-care plans. For the full anatomical breakdown of Types E1 through E5 — the subclasses that drive case value at the top of the severity distribution — see Strasberg Type E bile duct injury.

Published verdict and settlement data for Type E1 and E2 cases shows a general range of high six to low seven figures — roughly $800,000 to $2.5 million when reconstruction is performed by an experienced hepatobiliary surgeon with a good immediate outcome. Within that range, younger patients with high earning capacity and long life expectancy typically sit at the upper end; older patients with modest earning capacity and shorter remaining life expectancy typically sit at the lower end.

The life-care plan is the dominant component. A well-built life-care plan for an E1–E2 reconstruction patient includes annual hepatobiliary-specialist visits over the remaining lifespan, periodic magnetic resonance cholangiopancreatography (MRCP), probabilistic allowances for ERCP stricture dilation (published literature supports a 10% to 30% lifetime risk), surgical-revision allowances where the case series support them, and the medications, imaging, and allied-health services that follow a hepaticojejunostomy patient indefinitely. A hepatobiliary surgeon expert reviews and co-signs the plan; an economist reduces the projected costs to present value.

The figures here are patterns in published cases. No firm can tell you, at intake, what your specific case will resolve for. What a firm should be able to tell you is how the life-care plan is built, what the jurisdictional damages rules are, and what the general range looks like for comparable cases — with every qualifier attached.

Types E3 through E5 describe injuries at or above the confluence of the right and left hepatic ducts — E3 at the confluence, E4 destroying the confluence and separating the right and left systems, E5 involving the bifurcation plus an aberrant right hepatic duct. These are the highest-severity bile duct injuries short of an injury involving the hepatic artery or producing acute liver failure, and the reconstruction is correspondingly complex.

Published case-value patterns for E3 through E5 injuries cluster at seven figures, frequently into low eight figures — general patterns ranging from roughly $1.5 million to $8 million or more, depending on reconstruction outcome, long-term stricture history, jurisdiction, and the economic profile of the patient. Higher figures appear in cases where the initial reconstruction failed and a second (or third) surgical revision was required, and in cases where comparative negligence is not in dispute and the plaintiff's liability case is clean.

The reconstruction complexity maps to the damages. E4 injuries in particular — where the two hepatic ducts are separated and must be reconstructed separately — carry higher long-term stricture rates and more probabilistic allowances in the life-care plan. Cases that develop secondary biliary cirrhosis, portal hypertension, or recurrent cholangitis requiring hospitalization generate the highest damages models in this class.

A word on jurisdiction in this tier. An identical E4 injury in a state with no non-economic cap (Florida, Illinois, Missouri, Washington) produces a different total damages figure than the same injury in a state with a hard cap (Texas § 74.301, California MICRA as revised by AB 35). Forum matters enormously at the top of the severity distribution, and forum analysis is part of initial case strategy.

The highest-severity outcomes — acute liver failure requiring transplant, chronic liver failure with decompensation, and wrongful death — sit above the E-class framework and generate the highest damages models in bile duct injury practice. These cases are uncommon but they are the cases that shape public perception of what bile duct injury litigation can achieve.

Transplant cases carry the largest life-care plans in all of surgical litigation. A patient transplanted in their forties or fifties faces lifetime immunosuppression, monitoring, allowances for rejection episodes, probabilistic re-transplantation, and the substantially elevated morbidity and mortality that follow transplant recipients over decades. Published settlement and verdict data for liver transplant cases following bile duct injury shows low to mid eight figures in the general range of $5 million to $20 million or more in favorable jurisdictions, particularly when reconstruction was delayed and the progression to transplant was arguably preventable.

Wrongful death cases — where a missed bile duct injury progressed to sepsis, cholangitis, and death — have their own damages framework in every state, governed by state wrongful death statutes. In Florida, the Florida Wrongful Death Act, Fla. Stat. § 768.16–§ 768.26, governs the recovery and the eligible survivors. In Illinois, the Illinois Wrongful Death Act, 740 ILCS 180/ does the equivalent. Each state's statute is specific, and the recoverable damages vary meaningfully.

Published verdict and settlement data for wrongful death bile duct cases shows the widest distribution of any subset — general ranges from seven figures into eight figures, with specific figures depending heavily on the survivors (spouse, minor children, adult children), the economic support projected to have been lost, and the jurisdiction's treatment of non-economic wrongful death damages. These are patterns in published cases. They are not guarantees and they are not predictions.

Within every Strasberg class above, the published range is wide. What explains the spread? Several recurring factors drive variation within each class, and any firm evaluating a case takes them into account from the first records review. The mechanical line-item accounting of how these factors resolve into a specific number is set out on how gallbladder malpractice case value is calculated:

• Age and life expectancy. A 35-year-old patient with a Type E2 injury has decades of projected future medical costs and lost earning capacity ahead; a 72-year-old patient with the same injury has a meaningfully smaller forward-looking damages model. Age is the single most mechanical driver of variation.
• Occupation and earning capacity. A surgeon, pilot, or professional athlete whose occupation cannot accommodate the post-reconstruction limitations generates a larger lost-earning-capacity claim than a patient whose work can accommodate them. Vocational experts project both pathways and economists present-value them.
• Time-to-diagnosis. The literature is consistent — prompt intraoperative recognition produces better outcomes than late diagnosis. A Type D injury recognized on the table and repaired by a hepatobiliary surgeon on the same admission has a meaningfully different damages trajectory than the same injury missed for six weeks. Time-to-diagnosis can shift a case by a full severity tier.
• State damages law. Some states cap non-economic damages (Texas, California, Colorado, Ohio, Nebraska, and others); some do not (Florida after Kalitan, Illinois after Lebron v. Gottlieb, Missouri after Watts v. Cox Medical Centers, Washington after Sofie v. Fibreboard, Oregon after Horton v. OHSU, New Hampshire after Brannigan v. Usitalo). The practical effect is significant — in some jurisdictions, two identical cases produce two materially different settlements.
• Comparative negligence doctrine. Pure comparative, modified comparative (50% or 51% bar), and contributory negligence jurisdictions treat plaintiff fault differently. This rarely matters in bile duct cases because the patient does not typically share fault, but it does matter where informed-consent disputes are joined with the negligence claim.
• Insurance policy limits. Every figure above assumes coverage exists to pay it. Some bile duct cases are against solo practitioners with $1M/$3M coverage; others are against multi-hospital systems with substantial excess layers. Policy-limit demand practice and bad-faith doctrine — where applicable under state law — shape what can be recovered in practice.

Every one of these factors has to be examined before any range is offered. The figures above are patterns observed in the published verdict and settlement literature, published outcome series, and reported case law. Each is paired with the same disclaimer: no attorney can promise a result. Every case is resolved on its specific records and its specific jurisdiction. If you have a bile duct injury and you want to understand what drives the range in your specific case, a careful records review — by a firm that has handled these cases before — is where the honest answer starts. Start with a free consultation. Additional context on severity is available in the parent settlement guide and the common bile duct injury mini-hub.